ConductScience.org, home

Paper2986291

Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients.

Barin F and 5 others. Science, 1985. Cited by 246 papers, by iCite.

Cite this record

ConductScience Library. Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Papers, record 2986291. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2986291

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients.
PubMed
Journal
Science
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
246
iCite
Relative citation ratio, by iCite
5.94
iCite
Revised in PubMed
2019-06-18
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Barin FF
2McLane MFM F
3Allan JSJ S
4Lee THT H
5Groopman JEJ E
6Essex MM

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acquired Immunodeficiency SyndromeMajor topic
Antibodies, ViralMajor topic
Antigens, ViralMajor topic
DeltaretrovirusMajor topic
Viral Envelope ProteinsMajor topic
Antibody Specificity
Electrophoresis, Polyacrylamide Gel
Humans
Immunologic Techniques
Molecular Weight

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
2T32-CA09031NCI NIH HHSUnited StatesT32CA009031PubMed and NIHNIH RePORTER
CA 13885NCI NIH HHSUnited StatesR01CA013885PubMed and NIHNIH RePORTER
CA 37466NCI NIH HHSUnited StatesU01CA037466PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by74

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 246 citations.

PMIDTitleJournalYearIn PapersSource
39508605Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation.J Virol2024https://conductscience.org/library/papers/39508605PubMed
35335016Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities.Vaccines (Basel)2022https://conductscience.org/library/papers/35335016PubMed
30115684Metabolic labeling of HIV-1 envelope glycoprotein gp120 to elucidate the effect of gp120 glycosylation on antigen uptake.J Biol Chem2018https://conductscience.org/library/papers/30115684PubMed
27802337Characterization of Humoral Immune Responses against Capsid Protein p24 and Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type 1 in China.PLoS One2016https://conductscience.org/library/papers/27802337PubMed
23903848Isolate-specific differences in the conformational dynamics and antigenicity of HIV-1 gp120.J Virol2013https://conductscience.org/library/papers/23903848PubMed
22864288Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimer.Nat Struct Mol Biol2012https://conductscience.org/library/papers/22864288PubMed
20980495The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter.J Virol2011https://conductscience.org/library/papers/20980495PubMed
20716359Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies.Retrovirology2010https://conductscience.org/library/papers/20716359PubMed
20219932Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity.J Virol2010https://conductscience.org/library/papers/20219932PubMed
19763269Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.PLoS Pathog2009https://conductscience.org/library/papers/19763269PubMed
18768967Importance of the V1/V2 loop region of simian-human immunodeficiency virus envelope glycoprotein gp120 in determining the strain specificity of the neutralizing antibody response.J Virol2008https://conductscience.org/library/papers/18768967PubMed
18310320Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18310320PubMed
17942537Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection.J Virol2008https://conductscience.org/library/papers/17942537PubMed
16145089Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots.J Clin Microbiol2005https://conductscience.org/library/papers/16145089PubMed
15016849N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.J Virol2004https://conductscience.org/library/papers/15016849PubMed
14715727Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen.J Clin Microbiol2004https://conductscience.org/library/papers/14715727PubMed
10846104Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41.J Virol2000https://conductscience.org/library/papers/10846104PubMed
9817891Rapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2.J Clin Microbiol1998https://conductscience.org/library/papers/9817891PubMed
9114392Detection of human immunodeficiency virus type 1 (HIV-1) antibody by western blotting and HIV-1 DNA by PCR in patients with AIDS.J Clin Microbiol1997https://conductscience.org/library/papers/9114392PubMed
8548538Characteristics and clinical significance of a stabilization assay to detect specific antibodies to reverse transcriptase of human immunodeficiency virus.Clin Diagn Lab Immunol1995https://conductscience.org/library/papers/8548538PubMed

See all 74 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
ENPEP2028PubTator's text mininghttps://conductscience.org/library/genes/2028NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene
TMED210959PubTator's text mininghttps://conductscience.org/library/genes/10959NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2986291

GET https://conductscience.org/api/papers/v1/2986291/cited_by?page=2